Prophylactic Risedronate for Patients With Peripheral Lung Tumors Treated With SBRT
Clinical trial NCT03861091 · COMPLETED
Trial details
- NCT number
- NCT03861091
- Sponsor
- Wake Forest University Health Sciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-12
- Primary completion
- 2022-03-02
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.